A new nasal whooping cough vaccine showed ... at preventing whooping cough, caused by the Bordetella pertussis bacteria. However, the vaccines fail to clear bacteria from the upper respiratory ...

Whooping cough is a highly contagious respiratory disease spread by the bacteria Bordetella pertussis (pertussis is another ...

As whooping cough cases rise in the U.S., a new nasal vaccine developed ... caused by the Bordetella pertussis bacteria. However, the vaccines fail to clear bacteria from the upper respiratory ...

As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University may hold the key to reducing the spread of the highly contagious respiratory disease. Current pertussis ...

As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University may hold the key to reducing the spread of the highly contagious respiratory disease.

As whooping cough cases rise in the U.S., a new nasal vaccine developed ... caused by the Bordetella pertussis bacteria. However, the vaccines fail to clear bacteria from the upper respiratory ...

ILiAD Biotechnologies (ILiAD), a clinical-stage biotech company dedicated to the prevention and treatment of human disease ...

the leading next generation intranasal pertussis vaccine. This innovative medicine designation has been awarded to BPZE1 indicated for active immunization against both upper respiratory tract B.

ILiAD Biotechnologies (ILiAD), a clinical-stage biotech company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis and other respiratory pathogens ...